France Nuclear Imaging Market Size (2024 - 2029)

France Nuclear Imaging Market Analysis

The France Nuclear Imaging Market size is estimated at USD 412.91 million in 2024, and is expected to reach USD 483.58 million by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).

During the COVID-19 pandemic, the nuclear imaging market in France was significantly affected as a result of lockdown and restrictions on non-essential procedures. According to a study titled 'Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study' published in the National Center for Biotechnology Information in June 2021, the total number of nuclear medicine examinations performed in France dropped by 43.4% in the time span of 4 weeks before and after the lockdown. However, after the COVID-19 pandemic, the market is gaining its momentum back. Therefore, it is observed that despite the decrease in utilization of nuclear imaging during the pandemic, the market is believed to witness steady growth in the coming years.

The studied market growth can largely be attributed to factors, such as the increasing prevalence of cancer and cardiac disorders, and technological advancements in nuclear imaging. Morover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, in France, there are about 21.1% of people aged 65 years and above. As the older population is most likely to get affected by chronic diseases, the need for devices for monitoring, diagnosis, and treatment is expected to increase over the forecast period. Thereby boosting the growth of the market studied.

Additionally, technological advancements in nuclear imaging are augmenting the growth of the market studied in France. For instance, in May 2022, physicians from Baclesse Cancer Center, France demonstrated that an artificial intelligence (AI) program can enhance image quality in half-count F-18 FDG-PET scans, opening the door to large acquisition time reductions in standard clinical practice. With the findings from various studies, nuclear medicine specialists from France have started implementing advanced technologies in PET/SPECT scans which is expected to contribute to the growth of the market studied.

France Nuclear Imaging Industry Segmentation

As per the scope of this report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. France Nuclear Imaging market is segmented by Product (Equipment, Diagnostic Radioisotope), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.